Beam Therapeutics

Develops base editing–based precision medicines

Director of Financial Planning and Analysis - Commercial

Corporate Finance & FP&AConfirmed live in the last 24 hours

Full-timeCambridge, MA, USA$210k - $260k

About the Job

Requirements

Typically 12+ years of experience, including 8+ years of FP&A experience; biotech industry experience is strongly preferred.
A bachelor's degree in finance or accounting, or equivalent.
Knowledge of financial statements and understanding of United States generally accepted accounting principles (US GAAP).
Ability to meet deadlines while executing multiple deliverables.
Advanced financial modeling expertise, including building models from the ground up in Excel and/or planning tools.
Comfort utilizing and incorporating available artificial intelligence tools into work processes.
Advanced understanding of Excel, Adaptive Insights, and enterprise resource planning systems, preferably NetSuite or SAP.
Expected to work onsite 1–3 days per week.

Responsibilities

Serve as FP&A business partner to Commercial and the risto-cel program.
Oversee planning cycle activities and review and ensure accuracy of plan data for all partner functions and programs.
Conduct monthly budget-versus-actual analysis for partner functions and programs, and finance and management results.
Track risks and opportunities to the annual budget and enter material changes into the rolling forecast.
Assist in overall budget, long-range plan (LRP), and forecast processes outside partnership duties.
Partner with Commercial and Manufacturing to assess risto-cel commercial patient forecasts and pressure-test assumptions and outputs.
Partner with Accounting and Commercial to assess risto-cel commercial revenue forecasts and pressure-test assumptions and outputs.
Partner with Commercial to assess patient and revenue forecasts and pressure-test assumptions for additional commercial launches and pipeline commercial opportunities.
Build and maintain complex, integrated financial models supporting long-range planning, valuation, and strategic decision-making to assess key business risks and opportunities.
Complete special projects as required.

Desired Qualifications

Biotech industry experience is strongly preferred.
Advanced understanding of NetSuite or SAP is preferred.

Company Overview:

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview:

The Director, Financial Planning and Analysis, Commercial, will be a key member of the FP&A team reporting to the VP of FP&A. The focus of this position will be managing the planning processes and serving as the business partner to the Commercial organization and working cross-functionally to ensure accuracy of commercial revenue projections. This position will also be responsible for most financial modeling projects on the FP&A team and interact closely with the accounting team on the month end closing process.

Responsibilities

FP&A business partner to the Commercial, and risto-cel program.
Oversee planning cycle activities and review and ensure accuracy of plan data for all partner functions and programs.
Conduct monthly budget vs. actual analysis for partner functions and programs and finance/management results.
Track risks and opportunities to the annual budget and enter material changes into rolling forecast.
Assist in the overall budget, LRP, and forecast processes outside of partnership duties.
Partner with Commercial and Manufacturing to assess risto-cel commercial patient forecasts and pressure test assumptions and outputs.
Partner with Accounting and Commercial to assess risto-cel commercial revenue forecasts and pressure test assumptions and outputs.
Partner with Commercial to assess patient and revenue forecasts and pressure test assumptions for additional commercial launches and pipeline commercial opportunities.
Build and maintain complex, integrated financial models supporting long-range planning, valuation, and strategic decision-making to assess key business risks and opportunities.
Special projects as required.

Requirements

Typically 12+ years of experience with 8+ years of FP&A experience; biotech industry experience strongly preferred.
Bachelor’s degree in finance or accounting or equivalent.
Financial statement knowledge and understanding of US GAAP.
Strong team player that has a customer service approach and is solution oriented.
Ability to work within and meet all deadlines while executing on multiple deliverables.
Enjoy working in a fast-paced, high-volume environment.
Advanced financial modeling expertise with the ability to build models from the ground up in Excel and/or planning tools.
Comfort utilizing and incorporating available AI tools into work processes.
Advanced understanding of Excel, Adaptive Insights, and ERP systems (preferably NetSuite or SAP).
Candidates are expected to come onsite 1-3 days per week.

The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.

Beam Pay Range

$210,000—$260,000 USD

Beam Pay Range 210000 - 260000 USD

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size: 501-1,000
Company stage: IPO
Headquarters: Cambridge, MA
Founded: 2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs